Banco Santander S.A. (SAN)
13.74
+0.09 (0.66%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13G/A Sanofi Filed by: Amundi
July 22, 2026 9:50 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jun 30
July 22, 2026 6:11 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jun 30
July 22, 2026 6:07 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jun 30
July 22, 2026 6:05 AM - SEC Filing
Form 6-K SEABRIDGE GOLD INC For: Jul 21
July 22, 2026 6:02 AM - SEC Filing
Banco Santander S.A. (SAN) Reports Q2 EPS of EUR0.25
July 22, 2026 2:16 AM - StreetInsider
Sanofi reshapes executive committee effective September 2026
July 21, 2026 12:05 PM - StreetInsider
Press Release: Sanofi evolves its Executive Committee to support its next strategic chapter
July 21, 2026 12:00 PM - Globe NewsWire
Form 6-K SEABRIDGE GOLD INC For: Jul 20
July 20, 2026 10:49 AM - SEC Filing
Form 6-K Sanofi For: Jul 17
July 17, 2026 6:04 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jul 16
July 16, 2026 6:25 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR13.70 at Barclays
July 14, 2026 4:51 AM - StreetInsider
Form 6-K BANCO SANTANDER CHILE For: Jun 30
July 10, 2026 5:17 PM - SEC Filing
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
July 10, 2026 8:35 AM - Globe NewsWire
Form 6-K BANCO SANTANDER CHILE For: Jul 08
July 8, 2026 4:20 PM - SEC Filing
Form 6-K Sanofi For: Jul 07
July 7, 2026 9:02 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jul 02
July 2, 2026 6:17 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR13.50 at Morgan Stanley
July 2, 2026 4:35 AM - StreetInsider
Form 11-K Sanofi For: Dec 31
June 30, 2026 1:28 PM - SEC Filing
Form 11-K Sanofi For: Dec 31
June 30, 2026 12:54 PM - SEC Filing
Form NT 11-K Sanofi For: Dec 31
June 30, 2026 11:49 AM - SEC Filing
Form NT 11-K Sanofi For: Dec 31
June 30, 2026 11:45 AM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Jun 24
June 24, 2026 4:20 PM - SEC Filing
Banco Santander Chile: Second Quarter 2026 Analyst and Investor Webcast / Conference Call
June 24, 2026 10:57 AM - Globe NewsWire
Form 6-K Sanofi For: Jun 24
June 24, 2026 8:44 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR13.45 at Citi
June 23, 2026 5:03 AM - StreetInsider
Form 6-K Sanofi For: Jun 22
June 22, 2026 8:43 AM - SEC Filing
Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
June 22, 2026 2:00 AM - Globe NewsWire
Sanofi wins Japan approval for Sarclisa SC in multiple myeloma
June 19, 2026 6:31 AM - StreetInsider
Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
June 19, 2026 6:31 AM - Globe NewsWire
Form 6-K Banco Santander, S.A. For: Jun 18
June 18, 2026 6:17 AM - SEC Filing
Why does Barclays say it’s time to buy this Spanish stock?
June 13, 2026 4:00 AM - StreetInsider
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
June 12, 2026 6:10 PM - Globe NewsWire
Form 6-K BANCO SANTANDER CHILE For: May 31
June 12, 2026 1:36 PM - SEC Filing
Form 6-K Sanofi For: Jun 12
June 12, 2026 11:42 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jun 10
June 10, 2026 6:08 AM - SEC Filing
Form SC TO-I/A Banco Santander, S.A. Filed by: Banco Santander, S.A.
June 10, 2026 6:04 AM - SEC Filing
Form 6-K Sanofi For: Jun 08
June 8, 2026 6:07 AM - SEC Filing
Form CERT Banco Santander, S.A.
June 4, 2026 8:58 AM - SEC Filing
Form 8-A12B Banco Santander, S.A.
June 4, 2026 6:51 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jun 04
June 4, 2026 6:09 AM - SEC Filing
Press Release: Sanofi launches 2026 global employee stock purchase plan
June 4, 2026 4:07 AM - Globe NewsWire
Euro area loan growth edges up in April on stronger corporate lending
June 1, 2026 6:00 AM - StreetInsider
Form 6-K BANCO SANTANDER CHILE For: May 28
May 29, 2026 6:02 AM - SEC Filing
Form 424B5 Banco Santander, S.A.
May 28, 2026 12:54 PM - SEC Filing
Form SD Sanofi
May 28, 2026 6:07 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: May 27
May 28, 2026 6:02 AM - SEC Filing
Form FWP Banco Santander, S.A. Filed by: Banco Santander, S.A.
May 27, 2026 5:26 PM - SEC Filing
Form 6-K Sanofi For: May 27
May 27, 2026 10:32 AM - SEC Filing
Form SC TO-I Banco Santander, S.A. Filed by: Banco Santander, S.A.
May 27, 2026 6:15 AM - SEC Filing
Form 424B5 Banco Santander, S.A.
May 27, 2026 6:09 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: May 27
May 27, 2026 6:09 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: May 27
May 27, 2026 6:04 AM - SEC Filing
Webster Financial shareholders approve $12 billion Santander takeover
May 26, 2026 12:51 PM - StreetInsider
Sanofi reports positive phase 2 trial results for AATD treatment
May 18, 2026 3:30 PM - StreetInsider
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
May 18, 2026 3:30 PM - Globe NewsWire
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR12 at Jefferies
May 14, 2026 4:13 AM - StreetInsider
Form 6-K BANCO SANTANDER CHILE For: Apr 30
May 13, 2026 5:21 PM - SEC Filing
Santander US Survey Finds Resilient Consumers in Need of Vehicles, Used-Car Demand Persists
May 13, 2026 12:07 PM - BizWire
Form 6-K Banco Santander, S.A. For: May 13
May 13, 2026 10:06 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR12.75 at RBC Capital
May 12, 2026 2:00 AM - StreetInsider
Form 6-K BANCO SANTANDER CHILE For: Mar 31
May 11, 2026 4:26 PM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: May 11
May 11, 2026 2:43 PM - SEC Filing
Form 13F-HR Banco Santander, S.A. For: Mar 31
May 8, 2026 6:13 AM - SEC Filing
Form 13F-HR Sanofi For: Mar 31
May 7, 2026 8:47 AM - SEC Filing
Sanofi Supports AlphaDetect to Accelerate Detection of Alpha-1
May 6, 2026 12:42 PM - PR NewsWire
Form 6-K BANCO SANTANDER CHILE For: May 05
May 6, 2026 6:02 AM - SEC Filing
Form 6-K Sanofi For: May 05
May 5, 2026 6:08 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR12.10 at Deutsche Bank
May 5, 2026 5:25 AM - StreetInsider
Banco Santander SA (SAN:SM) (SAN) PT Lowered to EUR12.10 at Kepler Cheuvreux
May 5, 2026 5:21 AM - StreetInsider
Form 6-K Banco Santander, S.A. For: May 01
May 1, 2026 9:31 AM - SEC Filing
Form 6-K Santander UK plc For: May 01
May 1, 2026 9:21 AM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Mar 31
April 30, 2026 3:58 PM - SEC Filing
Banco Santander-Chile Announces First Quarter 2026 Earnings
April 30, 2026 8:01 AM - Globe NewsWire
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR12.70 at UBS
April 30, 2026 6:18 AM - StreetInsider
Form 6-K BANCO SANTANDER CHILE For: Apr 29
April 30, 2026 6:01 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR12.90 at Barclays
April 30, 2026 5:45 AM - StreetInsider
Form 6-K Banco Santander, S.A. For: Mar 31
April 29, 2026 4:12 PM - SEC Filing
Sanofi names Belén Garijo as CEO following shareholder approval
April 29, 2026 12:00 PM - StreetInsider
Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi
April 29, 2026 12:00 PM - Globe NewsWire
Form 6-K Banco Santander, S.A. For: Mar 31
April 29, 2026 6:14 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Mar 31
April 29, 2026 6:12 AM - SEC Filing
Form 6-K Sanofi For: Apr 29
April 29, 2026 6:11 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Mar 31
April 29, 2026 6:10 AM - SEC Filing
Form 6-K Sanofi For: Apr 27
April 27, 2026 12:58 PM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Apr 23
April 24, 2026 9:13 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Apr 24
April 24, 2026 6:28 AM - SEC Filing
Sanofi drug gets EU panel backing for progressive multiple sclerosis
April 24, 2026 6:10 AM - StreetInsider
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
April 24, 2026 6:09 AM - Globe NewsWire
Full Article List
